Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating
NCT ID: NCT00843219
Last Updated: 2016-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2009-03-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Evaluation of an amplitude based gated Positron Emission Tomography (PET) data acquisition system for all GE Discovery Positron Emission Tomography/ Computed Tomography (PET/CT) scanners.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dynamic FDG PET/CT: Optimization and Validation of Data Acquisition
NCT04660279
Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)
NCT03423407
Patient- and Task-specific Radiation Dose Optimization for Pediatric Abdominopelvic CT Applications
NCT03429712
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949
Study of Different Gating Techniques for PET Image of Lung and Liver Lesions
NCT05779865
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The PET/CT Scan:
If you agree to take part in this study, an elastic belt will be placed around your lower chest/upper abdomen before your routine PET/CT scan. This belt is used to track your breathing motion. This information will be used to help process the scan.
Your PET/CT scan will be performed as usual. During the scan, researchers will focus on your lower chest/upper abdomen (areas that experience breathing motion). Having to focus on this area might extend the scan by up to 10 minutes.
The additional scan time will not increase your radiation exposure since only PET scanning will be performed.
Length of Study:
Your participation on this study will be complete when your scheduled PET/CT scan is complete.
This is an investigational study. The imaging focused on your lower chest/upper abdomen during the scan is investigational.
Up to 26 patients will take part in this study. All will be enrolled at M. D. Anderson.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PET/CT Scan
PET/CT Scan
PET/CT scan performed with elastic belt around lower chest/upper abdomen to track breathing motion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PET/CT Scan
PET/CT scan performed with elastic belt around lower chest/upper abdomen to track breathing motion.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients that are scheduled to be imaged in the PET/CT suite at the Mays Building will only be considered.
Exclusion Criteria
2. Patients that cannot tolerate being scanned for an additional 10 minutes with arms above their head will be excluded.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GE Healthcare
INDUSTRY
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Osama R Mawlawi, PHD
Role: PRINCIPAL_INVESTIGATOR
UT MD Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UT MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
UT MD Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-0851
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.